AARC COPD Session Evaluation (ID: i725) Survey

Question Title

* 1. To receive CRCE/CME credit for completing this activity, please provide your full name, contact information, and complete the following evaluation.

*Name: *

*Degree & Specialty: *

*Address: *

AARC Member #

*City: *

*State: *

*ZIP: *

*Email Address: *

Phone Number:

Question Title

* 2. A hospitalized patient has a diagnosis of COPD confirmed with spirometry on day 2 of her hospital stay. She has an FEV1 of 57% predicted and FEV1/FVC of 0.68. She has had 2 exacerbations in the last year and her mMRC score is 2. What group is the patient’s COPD according to GOLD?

GOLD Group B

GOLD Group C

GOLD Group D

Question Title

* 3. Current GOLD guidelines recommend which of the following as initial pharmacotherapy for a patient diagnosed with GOLD Group B COPD?

SABA

LABA monotherapy

LAMA monotherapy

LABA or LAMA monotherapy

Question Title

* 4. On follow-up, a patient diagnosed with GOLD Group B COPD and currently treated with LAMA monotherapy continues to exhibit dyspnea and requires an escalation of therapy. Which of the following is the option recommended by GOLD?

LABA monotherapy

LABA + LAMA

LABA + ICS

Question Title

* 5. A 2017 meta-analysis found the combination of LABA + LAMA to be which of the following in comparison to LABA + ICS for improving lung function?

Equally effective

More effective

Less effective

Question Title

* 6. Following participation in this activity, how will you use self-management strategies to improve outcomes for your patients with COPD? (Select all that apply.)

Recommend specific/individual self-management strategies (eg, smoking cessation)

Utilize a comprehensive self-management education program

We do not educate patients on self-management

Question Title

* 7. Which of the following best describes the impact of this activity on your performance?

I will implement the information in my area of practice.

I need more information before I change my practice behavior.

This activity will not change my practice, as my current practice is consistent with the information presented.

This activity will not change my practice, as I do not agree with the information presented.

Question Title

* 8. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes.

Question Title

* 9. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 10. What barriers do you see to making changes in your practice?

Question Title

* 11. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

For questions 7-9, please rate your level of agreement by checking the appropriate rating.

Question Title

* 12. After participating in today’s activity, I am now able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Describe an approach to COPD treatment that is consistent with current evidence-based guideline recommendations	Describe an approach to COPD treatment that is consistent with current evidence-based guideline recommendations Strongly agree	Describe an approach to COPD treatment that is consistent with current evidence-based guideline recommendations Agree	Describe an approach to COPD treatment that is consistent with current evidence-based guideline recommendations Neutral	Describe an approach to COPD treatment that is consistent with current evidence-based guideline recommendations Disagree	Describe an approach to COPD treatment that is consistent with current evidence-based guideline recommendations Strongly disagree
Review the efficacy and safety of available long-acting bronchodilator therapies for COPD	Review the efficacy and safety of available long-acting bronchodilator therapies for COPD Strongly agree	Review the efficacy and safety of available long-acting bronchodilator therapies for COPD Agree	Review the efficacy and safety of available long-acting bronchodilator therapies for COPD Neutral	Review the efficacy and safety of available long-acting bronchodilator therapies for COPD Disagree	Review the efficacy and safety of available long-acting bronchodilator therapies for COPD Strongly disagree
Select appropriate medication delivery devices based on individual patient needs	Select appropriate medication delivery devices based on individual patient needs Strongly agree	Select appropriate medication delivery devices based on individual patient needs Agree	Select appropriate medication delivery devices based on individual patient needs Neutral	Select appropriate medication delivery devices based on individual patient needs Disagree	Select appropriate medication delivery devices based on individual patient needs Strongly disagree
Identify self-management strategies that reduce the risk of exacerbations and hospital readmissions for patients with COPD	Identify self-management strategies that reduce the risk of exacerbations and hospital readmissions for patients with COPD Strongly agree	Identify self-management strategies that reduce the risk of exacerbations and hospital readmissions for patients with COPD Agree	Identify self-management strategies that reduce the risk of exacerbations and hospital readmissions for patients with COPD Neutral	Identify self-management strategies that reduce the risk of exacerbations and hospital readmissions for patients with COPD Disagree	Identify self-management strategies that reduce the risk of exacerbations and hospital readmissions for patients with COPD Strongly disagree

Question Title

* 13. Antonio Anzueto, MD effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias	Avoided commercial bias Strongly agree	Avoided commercial bias Agree	Avoided commercial bias Neutral	Avoided commercial bias Disagree	Avoided commercial bias Strongly disagree

Question Title

* 14. Scott Cerreta, BS, RRT, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias	Avoided commercial bias Strongly agree	Avoided commercial bias Agree	Avoided commercial bias Neutral	Avoided commercial bias Disagree	Avoided commercial bias Strongly disagree

Question Title

* 15. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 16. Would you be willing to participate in a postactivity follow-up survey?

Yes

Question Title

* 17. Would you like to be contacted about future educational activities in your area of practice?

Yes

Question Title

* 18. Type of Credit:

AARC CRCE Credit

AMA PRA Category 1™ Credit

Question Title

* 19. Request for CME/CRCE Credit

I participated in the entire activity and claim 1.25 credits.

I participated in only part of the activity and claim 1.0 credit(s).

I participated in only part of the activity and claim 0.75 credit(s).

I participated in only part of the activity and claim 0.50 credit(s).

I participated in only part of the activity and claim 0.25 credit(s).